Please login to the form below

Not currently logged in
Email:
Password:

Protelos

This page shows the latest Protelos news and features for those working in and with pharma, biotech and healthcare.

CHMP turns down Avastin for brain cancer

CHMP turns down Avastin for brain cancer

Both drugs were originally rejected earlier this year. It also reported that Servier had elected to withdraw its application to extend the indications of its osteoporosis therapy Protelos/Osser (strontium ranelate)

Latest news

  • EMA recommends heart risk restriction for Servier's Protelos EMA recommends heart risk restriction for Servier's Protelos

    That review brought restrictions that included a prohibition on the use of Protelos' in immobilised patients or patients with a history of venous thromboembolism (VTE). ... This time around the PRAC wants the EMA's Committee for Medicinal Products for

  • Process for NICE guidance re-evaluation

    Servier Laboratories, the licence holder of Protelos (strontium ranelate), which instigated the review, remains satisfied with Mr Holman's judgement that NICE acted with procedural unfairness, and therefore unlawfully, by not

  • High Court rules against NICE in osteoporosis case

    The High Court has ruled that NICE must look again at its decision not to fund the use of osteoporosis drug Protelos on the NHS. ... The High Court has ruled that the National Institute for Health and Clinical Excellence (NICE) must look again at its

  • R&D News in brief

    Protelos shines in study. Servier's osteoporosis treatment, Protelos, is effective in reducing nonvertebral and vertebral fractures over five years, according to two new studies presented at the Sixth European Congress ... One trial of 1649

  • Food for thought

    Protelos - for osteoporosis. As a passionate believer in the relevant unexpected, I suppose this ad is totally relevant in its visual context but not entirely unexpected - unless one expects to see

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics